About Miromatrix
Miromatrix is a company based in Eden Prairie (United States) founded in 2009 was acquired by United Therapeutics in October 2023.. Miromatrix has raised $45.71 million across 10 funding rounds from investors including CareDx, United Therapeutics and HHS. The company has 77 employees as of December 31, 2022. Miromatrix operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Eden Prairie, United States
- Employees 77 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Miromatrix Medical Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$45.71 M (USD)
in 10 rounds
-
Latest Funding Round
-
Investors
CareDx
& 4 more
-
Employee Count
77
as on Dec 31, 2022
-
Acquired by
United Therapeutics
(Oct 30, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Miromatrix
Miromatrix has successfully raised a total of $45.71M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 10
- Last Round Last Round
-
First Round
First Round
(31 Jul 2009)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Series C - Miromatrix | Valuation | CareDx |
|
| Oct, 2019 | Amount | Grant - Miromatrix | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - Miromatrix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Miromatrix
Miromatrix has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include CareDx, United Therapeutics and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical solutions for transplant patients are developed and provided.
|
Founded Year | Domain | Location | |
|
Research and health information on diabetes and kidney diseases are provided by NIDDK.
|
Founded Year | Domain | Location | |
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Miromatrix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Miromatrix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Miromatrix Comparisons
Competitors of Miromatrix
Miromatrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Miromatrix
Frequently Asked Questions about Miromatrix
When was Miromatrix founded?
Miromatrix was founded in 2009.
Where is Miromatrix located?
Miromatrix is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
Who is the current CEO of Miromatrix?
Jeff Ross is the current CEO of Miromatrix.
Is Miromatrix a funded company?
Miromatrix is a funded company, having raised a total of $45.71M across 10 funding rounds to date. The company's 1st funding round was a Grant of $1.66M, raised on Jul 31, 2009.
How many employees does Miromatrix have?
As of Dec 31, 2022, the latest employee count at Miromatrix is 77.
What does Miromatrix do?
Miromatrix Medical was founded in 2009 in Eden Prairie, United States, within the biotechnology sector. Fully biological organs are developed for replacement in the human body, including targets such as the liver, lung, kidney, pancreas, and heart. A bioengineered mesh, derived from porcine liver through perfusion decellularization, is produced for applications in hernia repair and breast reconstruction. This process removes cellular components to create acellular scaffolds for surgical use.
Who are the top competitors of Miromatrix?
Miromatrix's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Who are Miromatrix's investors?
Miromatrix has 5 investors. Key investors include CareDx, United Therapeutics, HHS, National Institute of Diabetes and Digestive and Kidney Diseases, and State.